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Dr. Harold Rifkin*, has previously set forth the
reasons why we should try to keep the diabetic patient's blood sugar as near normal as possible. What
are the generally accepted standards of good diabetic
control?
Marble 1 considered control of the insulin-dependent diabetic good if the whole blood glucose before
meals was not over 130 mg% ( = serum glucose 150
mg%), the 24-hour urinary glucose did not exceed 5%
of the carbohydrate intake, and there was no ketonuria; Oakley et al2 defined satisfactory control as
blood glucose before meals of less than 150 mg% with
no hypoglycemia; Lewis et al,3 in a recent paper
dealing with pregnant diabetics, recommended fasting blood glucose below 100 mg% and blood glucose
two hours after break fast below 160 mg%.
In some diabetics we can accomplish this type of
control; in others we cannot. The maturity onset
diabetic has some endogenous insulin under autoregulatory feedback control and, with a judicious diet
or with the addition of a sulfonylurea drug or some
exogenous insulin, near normal blood sugars can be
achieved. However, in the juvenile or young adult
onset diabetic, with little or no endogenous insulin, it
is very difficult, even with complicated schedules of
administration of insulin, to get blood sugars anywhere near normal without producing hypoglycemia.
A reasonable goal for every diabetic would be to
maintain blood sugars as near normal as possible
without producing hypoglycemia and without requiring a program so restrictive that it interferes with the
quality of life.

* see precedin g

abstract.
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Figure l, taken from a paper by Molnar et al, 4
illustrates the daily variations in plasma insulin and
blood glucose throughout a 24-hour period in a normal individual. Meals, snacks, and standard exercise
periods are indicated. It is apparent that each feeding
is accompanied by a sharp peak in insulin secretion
which brings about disposal of ingested glucose and
amino acids, and limits the blood sugar rise.
It is obvious that no one injection of intermediate-acting insulin can in any way duplicate the
normal insulin pattern. At best an injection ofNPH®
or Lente® Insulin given before breakfast will be absorbed for the most part over the next 8 to 12 hours
when meals will be eaten, with some carry-over effect
during the night. As diabeticians we hope to accomplish blood sugar levels that average ,somewhere near
normal, but obviously the blood sugar will rise too
high after meals and .may fall too low before the next
meal. Further leveling out may be accomplished by
the addition of between-meal and bedtime snacks.
We always insist on midafternoon and bedtime
snacks in every patient on NPH ® or Lente® Insulin.
Bressler and Galloway 5 some years ago called
attention to variations in the timing of effect of various insulins (Fig 2). Diabetics were divided into those
showing a normal (B) response, a transient (A) response, or a delayed (C) response to NPH® or Lente®
Insulin . Those with a normal response could be moderately well regulated with a single morning injection
of NPH® or Lente® Insulin . Those with a transient
response might benefit from a second small dose of
NPH® or Lente® Insulin before supper, and those
with a delayed response might require the addition of
regular insulin to the morning dose of NPH® or
Lente® Insulin. The reasons for this variation in the
timing of effect of the intermediate-acting insulins is
not known . One possible factor delaying the action of
19
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mortality and morbidity ,3 although better obstetrical
techniques for monitoring the pregnancy and timing
of delivery are equally important factors in the improved outcome in these patiepts. Thus a number of
schedules of insulin administration have been proposed as illustrated in Table 1. There is good rationale for each of these programs in a given situation,
although it is unlikely that any one type of program
will be best for all patients.
Attempts have been made to define complicated
dosage schedules even more rigidly. Lewis et al3 recommend the following formula for insulin administration for pregnant diabetics:

Su

r

1:::~:~

o~
07

11

15

19

·

23

03

Morning NPH ®
Morning reg . ins.

2: I

Evening NPH®
Evening reg. ins. = I : I

07

Morning total

Clock time
Fig I-Meal-to-meal <1nd day-to-day variations in blood glucose
and immunoreactive insulin in a normal subject on two successive
days (solid line represents first day; interrupted line represents
second day). B = breakfast, L = lunch , Sk = snack, D = dinner,
Su = supper, E = exercise, one hour of walking.

insulin is its binding to antibodies, with subsequent
release, which prolongs the insulin effect.
Lukens,6 Forsham, 7 and others pointed out some
time ago that multiple injections of regular insulin
before meals, perhaps accompanied by one or more
injections of longer-acting insulin to control overnight blood sugar, would more closely resemble normal physiology and would be likely to give better
control than a single injection of long- or intermediate-acting insulin. Indeed it is doubtful whether
the medical profession did diabetic patients any favor
when some years ago it abandoned multiple insulin
injections in favor of the once-a-day injection of
longer-acting preparations. Once the diabetic public
became accustomed to the single morning injection it
was difficult to persuade patients to go back to multiple injections and, by and large, doctors hav~ seldom made the effort.
Recently there has been a renewal of interest in
the use of multiple injections of regular insulin to
accomplish more physiologic control, especially since
reports from Paris by Job et a1 8 seem to indicate that
such regimens in juvenile diabetics result in better
control and in less progression of retinopathy . Also,
especially good control in pregnant diabetics with
multiple injections appears to result in lower infant

=

2 X evening total

I have tried this schedule with several pregnant diabetics with quite varied results. I think the reasoning
is right, but it should be remembered that no two
diabetic patients will respond in exactly the same
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Fig 2-Blood sugar responses to a single daily dose of NPH ®
Insulin.
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TABLE I
Various Schedules for Insulin Administration

Breakfast

Lunch

Afternoon
Snack

Supper

Bedtime
Snack

N

R+ N
N

R
R

R
R

R+ N

N
N

R+ N
R+ N

(N = _NPH'" or Lente"' Insulin. R = regular or cry stalline
zinc insulin .)

way-there are just too many variables. Some of
these are listed in Table 2.
How then should one approach if)sulin treatment in any given patient? Two basic principles are
helpful: (I) analyze what kind of diabetic the patient
is, and (2) keep the variables at a minimum.
The first principle means to try to form some
idea of how much endogenous insulin the patient has
from evaluation of the age of onset of the diabetes,
his or her weight at onset, and the severity of symptoms at onset, especially weight loss . Onset of diabetes early in life, severe polyuria and polydipsia, and
especially weight loss from uncontrolled diabetes,
usually indicate total or near total insulin deficiency .
If the patient has been on treatment, the diabetician
should also consider the occurrence of ketoacidosjs

TABLE 2
Variable Factors Limiting Good Blood Sugar Control
with Exogenous Insulin
Variation s in food intake
Variation s in exercise
Emotional factors and oth er stresses
Factors a ffecting the a vailability and effecti ven ess of
administered insulin:
(a ) vari abl e absorption rates from inj ection site
(b) variable antibody titers and uncertain rates of release
of insulin from antibodies
(c) variations in receptor binding sites a nd in their
affinity for insulin
5. Va riations in glucagon secretion
6. Hypoglycemia with rebound hyperglycemia ca used b y
counter-regulatory factors
7. Exogenous insulin is delivered into systemic circulation
and not primarily into portal circulation and to the liver
a s is endogenously secreted insulin
I.
2.
3.
4.
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or frequent hypoglycemic reactions, both of which
suggest that the patient has little or no endogenous
insulin. If the patient has been controlled in the past
on oral agents he or she must have had some endogenous insulin at that time.
The second principle, keeping the variables at a
minimum, means trying to get the patient to maintain
reasonably constant eating habits and exercise patterns as well as simplifying the insulin schedule until
the need for multiple doses becomes apparent. In
general , begin with a single dose of NPH® or Lente®
Insulin every morning , perhaps 20 units if the patient
has never before taken insulin. Instruct the patient in
a proper diet, which probably should include both
afternoon and evening snacks, for his or her weight
and activity . The patient may continue working but
should test his or her urine four times daily , before
meals and at bedtime. If the patient continues to spill
sugar, increase the insulin by 5 units every four or five
days until some negative urine tests are obtained.
Check the blood sugar at the time of the negative
urine test , and if this is still high, continue to increase
the insulin until the blood sugar is in the desired
range. If any hypoglycemic reactions occur, the insulin dose should be reduced . As the patient approaches control the urine tests should be determined
from second voidings whenever the first voiding contains sugar.
Many diabetics will come under satisfactory
control with a single morning dose of NPH® or
Lente@ Insulin. If glycosuria or hyperglycemia persists before breakfast, with negative tests in the afternoon, the patient may be classified as a transient
responder, and a second small dose of N PH® or
Lente''9 Insulin should be added before supper. If the
morning test is repeatedly negative but glycosuria
persists before lunch, the patient may be a delayed
responder, and regular insulin can be added to the
morning NPH@.
If the desired degree of control is not achieved by
these measures, both regular and NPH ® Insulin may
be given twice daily . In general the indications for
administration of such multiple doses would follow a
schedule such as in Table 3, as suggested by Oakley et
al. 2
In a highly reliable and highly motivated patient,
such as a pregnant diabetic, this type of program may
succeed ; or a highly obsessive patient may religiously
seek perfect i:.;ontrol. Unfortunately most patients are
not so reliable, and the obsessive ones usually end up
making themselves hypoglycemic.
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TABLE 3
Management of the Severe Diabetic with Twice Daily
Injections of Re~ular and NPH® Insulin

Insulin
Morning RI
Morning NPH ®
Evening RI
Evening NPH '"'

Peridd of
Maximum Action

Timing of urine or
blood sugar for
dose adjustment

Breakfast to lunch
Lunch to supper
Supper to midnight
Midnight to breakfast

Pre-lunch
Pre-supper
Bedtime
Pre-breakfast

What do you do with the patient who never
shows any consistent pattern? You look for such
variables as food intake, exercise, emotional upsets,
and other factors . Hypoglycemia, recognized or unrecognized, is the cause of much brittleness. For every recognized hypoglycemic reaction, the brittle
juvenile diabetic has ten other occasions when the
blood sugar is quite low without his knowledge, and
each may be followed by rebound hyperglycemia.
You must learn to recognize this pattern and to reduce insulin accordingly. Tables 4 and 5 illustrate two
such patients.
Table 4 is a record of the urine sugars on a 23year-old dental student with diabetes of two years'
duration, during which he took 12 units of Semilente® and 20 units of Lente® Insulin daily. He was on
a 2500-calorie diet including three main meals and
midafternoon and bedtime snacks. He was extremely
conscientious and liked to keep all his urine tests
negative. To keep himself in physical trim he ran two

TABLE 4
Insulin Dosage and Urine Tests Showing Glycosuria
Following Asymptomatic and Unrecognized Hypoglycemia
J.S. (Male, 23)
Insulin
12 SL ± 20 L

Urine sugars
7

II

4

9

N
N
4+
N

N
N
4+
N
3+
3+
N
I+
N

N
N
N
N
N
N
N
N
N

N
N*
N
N*
N
N*
4+
N
N

2+
N
3+
4+
N

• Ran approximately 2 miles
(SL = Semilente® In sulin. L = Lente® Insulin .)

miles several times a week, and because of his busy
schedule chose the late evening as the time for his
exercise. He was not conscious of any hypoglycemic
reactions, but he invariably showed unexpected sugar
in his urine on the mornings after running; when he
had not run the night before, his tests were almost all
negative. It became apparent that the additional exercise was causing undetected hypoglycemia during the
night, followed by rebound hyperglycemia and glycosuria the next day, the so-called Somogyi effect
caused by the secretion of epinephrine, glucagon, cortisol, and growth hormone in response to hypoglycemia. The situation was corrected by insisting that
he take sizable extra feedings just before and just
after his nocturnal exercise periods; this prevented
the hypoglycemia and its consequent rebound.
The Somogyi rebound hyperglycemia following
hypoglycemia is most often seen in the brittle juvenile
diabetic, but can be observed in any insulin-dependent diabetic. Table 5 shows the record of urine tests
on a 72-year-old diabetic taking 32 units of NPH®
Insulin daily. He also was very conscientious and
very careful about his diet. After a series of days with
all negative urine tests, he showed unexpected 4+
sugar at noon on Aug 29 and Aug 30, with sugar

TABLE 5
Insulin Dosage and Urine Tests in an Older Diabetic
Showing Glycosuria, Probably Representing Rebound
After Unrecognized Hypoglycemia
J.Y.C. (Male, 72)
NPH®
8/ 27
8/ 28
8/ 29
8/ 30
8/ 31
9/ 1
9/ 2
9/ 3
9/ 4
9/ 5
9/ 6
9/7
9/ 8
9/ 9
9/ 10
9/ 11
9/ 12
9/ 13
9/ 14

32

30

7

12

5

9

N
N
N
N
N
N
N
tr
N
N
N
N
N
N
3+
N
3+
I+
N

N
N
4+
4+
N
tr
N
tr
N
N
N
N
tr
2+
3+

N
N
I+
4+
N
tr
3+
N
N
N
N
N
tr
N
N
4+
N
N
N

4+
N
3+
4+
N
N
3+
4+
N
N
N
N
4+
3+
4+
4+
N
N
N

2+
tr
3+
N
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persisting during the rest of the day. Questioning
revealed no dietary indiscretions, no variation in exercise, and no emotional upsets or other stresses to
account for the glycosuria. Although he was unaware
of any hypoglycemic symptoms, it seemed inconceivable that the dose of insulin which had kept his tests
all negative over the previous days could be so inadequate on these days. I suspected unrecognized
hypoglycemia and reduced his NPH® Insulin to 30
units. The urine tests improved and remained all
negative until Sep 8 when he again began to show
sugar in the evening test. Not shown in Table 5 is the
fact that his NPH® Insulin was lowered again to 28
units and later to 26 units with improvement each
time and, finally, all negative urine tests. He remained
on 26 units of NPH ® for several months, then began
to spill sugar in all specimens; the NPH® Insulin dose
has been gradually raised again to 30 units with good
control. The reason for these swings in insulin requirement over periods of several months is unknown. Some patients go through cycles when their
insulin requirement goes up or down for no apparent
reason; these may be over months or over shorter
periods. All we can do is to try to keep pace through
adjustments in insulin dose.
When the patient alternates between good days
and bad days, with lots of sugar or no sugar, suspect
hypoglycemia with rebound. In any event you should
adjust the patient's insulin dose to his or her better
days and not try to give more for the bad days or you
will surely produce hypoglycemia.
The bane of the diabetician 's existence is the
obese patient on insulin. If these patients could have
been made to reduce in the beginning, many of them
would not have needed insulin. Once on insulin, lipolysis is inhibited, weight reduction becomes even
more difficult, and these patients tend to gain more
weight which increases insulin resistance, creating a
vicious circle of upward spiraling weight and insulin
dosage. In this instance it may be better to cut back
the insulin dosage and let the patient spill sugar until
somehow he or she can be persuaded to really limit
food intake. There is no satisfactory answer to this
problem unless the patient loses weight.

23

In summary, I believe in aiming for the best
possible control for each patient through an empirical approach which seeks to arrive at the best schedule for the individual patient. We want especially
tight control for the pregnant diabetic, and for this
patient it is likely that multiple insulin injections are
needed. If further experience confirms the benefits of
multiple injections for juvenile patients, this type of
treatment may a1so be indicated for these patients.

Figure I is reproduced with permission from Mayo Clinic
Proceedings (47:709-719, 1972).

Figure 2 is reproduced with permission from Medical Clinics
of North America (55:861-868, 1971 ).
Table 3 is reproduced with permission from Diabetes
( 15:219-222, 1966).
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